Some experiences with a pan amalgamation mill, Guanacevi, Mexico

The work of the chemist and assayer at a pan amalgamation mill is cheifly sic routine work. The work of one day differs, generally, very little from the work of an other day. But occasionally some contingency arises which taxes his ability to the utmost --page 2

Reproducibility of body volume assessments in survival clothing in fixed and portable scanning systems.

The recent development of portable 3D scanning systems for industries such as animation and museum artefact digitisation have considerable potential for applications involving human body measurement. However, this requires a system for validation of measurements against a criterion, which this study aimed to provide. Forty four adult males were scanned in duplicate in both a fixed Hamamatsu and portable Artec L scanning systems in two postures and two different clothing assemblages. Following inspection of all scans, complete data for duplicate scans of 38 participants were available for the study. Both scanners demonstrated good precision, however significant differences in body volume prevailed for both egress and scanner postures in form-fitting clothing and the scanner posture in survival suit scans, with the Hamamatsu providing greater volumes than the Artec system (by 2.7, 2.8 and 2.1 litres respectively). Regression analysis indicated the results from the portable scanner explained between 96 and 98% of the variability in the results from the fixed scanner. The biases in body volume probably relate to different software approaches to its calculation, and a possible interaction with posture and clothing. Validation of the Artec against the Hamamatsu system provides valuable information for its use in field and industrial settings

Volumetric and space requirements of the offshore workforce: the effects of donning a survival suit.

Confined space working is common place within the offshore oil and gas infrastructure and it is a persons absolute size that governs their fit within this built environment. The design and adjustability of the environment must be based on the assumed size of the workforce; 95th percentile of the male size. The last anthropometric survey of the offshore workforce was conducted almost 30 years ago and since then the average weight of the workforce has increased by 19%; although the size and shape change associated with this increase remains unknown. With advances in portable 3D scanning technology and its potential for anthropometric measurement; this study aimed to quantify the volumetric and space requirements of the offshore workforce and size increases associated with donning personal protective equipment. Forty-three male participants were measured using both a static Hamamatsu and a portable Artec L 3D scanner in three different clothing assemblages. Volumetric and linear measures indicated a 71.3% increase in total body volume and a 101.9% gain in space requirements associated with donning a survival suit. Size increases due to survival clothing was found to have a close relationship with BMI; smaller individuals increase in body volume and space requirements more than their larger counterparts, r = 0.815 and r = 0.659 respectively. This pilot study identifies a need for further research into space requirements, especially in confined spaces and using specialist clothing

A Candidate Brightest Proto-Cluster Galaxy at z = 3.03

We report the discovery of a very bright (m_R = 22.2) Lyman break galaxy at z = 3.03 that appears to be a massive system in a late stage of merging. Deep imaging reveals multiple peaks in the brightness profile with angular separations of ~0.''8 (~25 h^-1 kpc comoving). In addition, high signal-to-noise ratio rest-frame UV spectroscopy shows evidence for ~5 components based on stellar photospheric and ISM absorption lines with a velocity dispersion of sigma ~460 km s^-1 for the three strongest components. Both the dynamics and high luminosity, as well as our analysis of a LCDM numerical simulation, suggest a very massive system with halo mass M ~ 10^13 M_solar. The simulation finds that all halos at z = 3 of this mass contain sub-halos in agreement with the properties of these observed components and that such systems typically evolve into M ~ 10^14 M_solar halos in groups and clusters by z = 0. This discovery provides a rare opportunity to study the properties and individual components of z ~ 3 systems that are likely to be the progenitors to brightest cluster galaxies.Comment: 14 pages, 3 figures, submitted to ApJ Letter

A new waist-to-height ratio predicts abdominal adiposity in adults.

Our aim was to identify the best anthropometric index associated with waist adiposity. The six weight-status indices included body mass index (BMI), waist-to-hip ratio (WHR), waist-to-height ratio (WHTR), and a new waist-by-heigh

Far-ultraviolet Spectroscopy of Venus and Mars at 4 A Resolution with the Hopkins Ultraviolet Telescope on Astro-2

Far-ultraviolet spectra of Venus and Mars in the range 820-1840 A at 4 A resolution were obtained on 13 and 12 March 1995, respectively, by the Hopkins Ultraviolet Telescope (HUT), which was part of the Astro-2 observatory on the Space Shuttle Endeavour. Longward of 1250 A, the spectra of both planets are dominated by emission of the CO Fourth Positive band system and strong OI and CI multiplets. In addition, CO Hopfield-Birge bands, B - X (0,0) at 1151 A and C - X (0,0) at 1088 A, are detected for the first time, and there is a weak indication of the E - X (0,0) band at 1076 A in the spectrum of Venus. The B - X band is blended with emission from OI 1152. Modeling the relative intensities of these bands suggests that resonance fluorescence of CO is the dominant source of the emission, as it is for the Fourth Positive system. Shortward of Lyman-alpha, other emission features detected include OII 834, OI lambda 989, HI Lyman-beta, and NI 1134 and 1200. For Venus, the derived disk brightnesses of the OI, OII, and HI features are about one-half of those reported by Hord et al. (1991) from Galileo EUV measurements made in February 1990. This result is consistent with the expected variation from solar maximum to solar minimum. The ArI 1048, 1066 doublet is detected only in the spectrum of Mars and the derived mixing ratio of Ar is of the order of 2%, consistent with previous determinations.Comment: 8 pages, 5 figures, accepted for publication in ApJ, July 20, 200

Greenhouse Gas Emissions from U.S. Hydropower Reservoirs: FY2011 Annual Progress Report

The primary objective of this study is to quantify the net emissions of key greenhouse gases (GHG) - notably, CO{sub 2} and CH{sub 4} - from hydropower reservoirs in moist temperate areas within the U.S. The rationale for this objective is straightforward: if net emissions of GHG can be determined, it would be possible to directly compare hydropower to other power-producing methods on a carbon-emissions basis. Studies of GHG emissions from hydropower reservoirs elsewhere suggest that net emissions can be moderately high in tropical areas. In such areas, warm temperatures and relatively high supply rates of labile organic matter can encourage high rates of decomposition, which (depending upon local conditions) can result in elevated releases of CO{sub 2} and CH{sub 4}. CO{sub 2} and CH{sub 4} emissions also tend to be higher for younger reservoirs than for older reservoirs, because vegetation and labile soil organic matter that is inundated when a reservoir is created can continue to decompose for several years (Galy-Lacaux et al. 1997, Barros et al. 2011). Water bodies located in climatically cooler areas, such as in boreal forests, could be expected to have lower net emissions of CO{sub 2} and CH{sub 4} because their organic carbon supplies tend to be relatively recalcitrant to microbial action and because cooler water temperatures are less conducive to decomposition

Pressure and Volume Limited Ventilation for the Ventilatory Management of Patients with Acute Lung Injury: A Systematic Review and Meta-Analysis

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life threatening clinical conditions seen in critically ill patients with diverse underlying illnesses. Lung injury may be perpetuated by ventilation strategies that do not limit lung volumes and airway pressures. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing pressure and volume-limited (PVL) ventilation strategies with more traditional mechanical ventilation in adults with ALI and ARDS.We searched Medline, EMBASE, HEALTHSTAR and CENTRAL, related articles on PubMed™, conference proceedings and bibliographies of identified articles for randomized trials comparing PVL ventilation with traditional approaches to ventilation in critically ill adults with ALI and ARDS. Two reviewers independently selected trials, assessed trial quality, and abstracted data. We identified ten trials (n = 1,749) meeting study inclusion criteria. Tidal volumes achieved in control groups were at the lower end of the traditional range of 10-15 mL/kg. We found a clinically important but borderline statistically significant reduction in hospital mortality with PVL [relative risk (RR) 0.84; 95% CI 0.70, 1.00; p = 0.05]. This reduction in risk was attenuated (RR 0.90; 95% CI 0.74, 1.09, p = 0.27) in a sensitivity analysis which excluded 2 trials that combined PVL with open-lung strategies and stopped early for benefit. We found no effect of PVL on barotrauma; however, use of paralytic agents increased significantly with PVL (RR 1.37; 95% CI, 1.04, 1.82; p = 0.03).This systematic review suggests that PVL strategies for mechanical ventilation in ALI and ARDS reduce mortality and are associated with increased use of paralytic agents

Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial

BackgroundThe majority of patients using antihypertensive medications fail to achieve their recommended target blood pressure. Poor daily adherence with medication regimens and a lack of persistence with medication use are two of the major reasons for failure to reach target blood pressure. There is no single intervention to improve adherence with antihypertensives that is consistently effective. Community pharmacists are in an ideal position to promote adherence to chronic medications. This study aims to test a specific intervention package that could be integrated into the community pharmacy workflow to enable pharmacists to improve patient adherence and/or persistence with antihypertensive medications - Hypertension Adherence Program in Pharmacy (HAPPY).Methods/DesignThe HAPPY trial is a multi-centre prospective randomised controlled trial. Fifty-six pharmacies have been recruited from three Australian states. To identify potential patients, a software application (MedeMine CVD) extracted data from a community pharmacy dispensing software system (FRED Dispense&reg;). The pharmacies have been randomised to either \u27Pharmacist Care Group\u27 (PCG) or \u27Usual Care Group\u27 (UCG). To check for \u27Hawthorne effect\u27 in the UCG, a third group of patients \u27Hidden Control Group\u27 (HCG) will be identified in the UCG pharmacies, which will be made known to the pharmacists at the end of six months. Each study group requires 182 patients. Data will be collected at baseline, three and six months in the PCG and at baseline and six months in the UCG. Changes in patient adherence and persistence at the end of six months will be measured using the self-reported Morisky score, the Tool for Adherence Behaviour Screening and medication refill data.DiscussionTo our knowledge, this is the first research testing a comprehensive package of evidence-based interventions that could be integrated into the community pharmacy workflow to enable pharmacists to improve patient adherence and/or persistence with antihypertensive medications. The unique features of the HAPPY trial include the use of MedeMine CVD to identify patients who could potentially benefit from the service, control for the \u27Hawthorne effect\u27 in the UCG and the offer of the intervention package at the end of six months to patients in the UCG, a strategy that is expected to improve retention.Trial RegistrationAustralian New Zealand Clinical Trial Registry ACTRN12609000705280<br /